Stéphane Bancel, Moderna CEO (Photographer: Christopher Goodney/Bloomberg via Getty Images)
April 11, 2024 11:42 AM EDT
Manufacturing

Mod­er­na halts African fa­cil­i­ty build as Covid-19 vac­cine de­mand plum­mets

Anna Brown

News Reporter

Mod­er­na’s man­u­fac­tur­ing fu­ture in Africa is less clear af­ter the com­pa­ny held back plans to build an mR­NA vac­cine pro­duc­tion site in Kenya.

“Mod­er­na has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times